Related Experiment Video
Updated: May 5, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Genomics in Health and Biomedicine
Maria Luís Cardoso1,2, Hugo Martiniano1,2, Luisa Mota-Vieira2,3
1Departamento de Promoção da Saúde e Prevenção de Doenças não Transmissíveis, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Abstract:
Genomic information is rapidly becoming a cornerstone of personalized medicine, offering transformative potential for clinical practice. This chapter explores the critical role of genomics in enabling earlier diagnosis, precise treatment, risk prediction, and preventive healthcare strategies. Advances in sequencing technologies, data integration, and bioinformatics allow for tailored healthcare solutions based on an individual's genetic profile, combined with clinical, lifestyle, and environmental data. Integration with electronic health records, mHealth technologies, and artificial intelligence further enhances clinical decision-making. The chapter highlights current applications of genomic medicine in oncology, rare diseases, and pharmacogenomics and the growing relevance of polygenic risk scores in managing common chronic diseases. It also discusses the need for harmonized data governance, infrastructure development, professional training, and public engagement to ensure equitable and effective implementation. These developments are situated within the broader landscape of national and international initiatives-including ICPerMed, 1Million Genomes, and the Genome of Europe project-that aim to foster collaboration, standardization, and equitable access to genomic healthcare across populations. Clinical areas where genomics has already demonstrated substantial value are discussed while identifying key challenges and priorities for advancing the future of personalized medicine.
Related Concept Videos
Genomics
Pharmacogenetics and Pharmacogenomics: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

